Skip to main content
. 2020 Nov;9(11):6963–6987. doi: 10.21037/tcr-20-2303

Table 5. Regression analyses of ORR in the XELOX group.

ORR Coef. Std. Err. t P 95% CI
Study type –0.2529 0.112954 –2.24 0.052 –0.50842 to 0.002623
Gender 0.422701 0.484584 0.87 0.406 –0.673505 to 1.518906
_cons 0.262381 0.294841 0.89 0.397 –0.404595 to 0.929357

ORR, objective response rate; XELOX, oxaliplatin combined with capecitabine; Coef., coefficient; Std. Err., standard error; CI, confidence interval.